查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571469

西方印渍术市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区、细分市场预测，2024-2030 年

Western Blotting Market Size, Share & Trends Analysis Report, By Type (Instruments), By Application (Biomedical & Biochemical Research, Disease Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

西方印渍术市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，预计到 2030 年，全球西方印渍术市场规模将达到 14.8 亿美元，2024 年至 2030 年复合年增长率为 6.1%。

感染爱滋病毒的人数不断增加，对市场的成长做出了越来越大的贡献。这种类型的测试对于检测人群中的爱滋病毒非常有效。根据联合国爱滋病规划署的数据，2015 年全球有近 3,670 万人感染爱滋病毒。如此高的爱滋病毒感染率预计将加速对用于西方印渍术的产品的需求。莱姆病也需要西方印渍术来检测导致此类疾病的伯氏疏螺旋体 (Bb)。其他需要蛋白质印迹检测特定蛋白质的疾病包括狂牛症、肝炎和猫免疫力缺乏。

此外，製药和生物技术公司对研发活动的大量投资预计将推动西方印渍术市场的成长。根据新闻日誌报道，生技公司 2015 年在研发活动上花费了 401 亿美元，比 2014 年的投资成长了 16%。因此，随着研究和开发活动的增加，预计在不久的将来对西方印渍术测试的需求将会增加。

西方印渍术市场报告亮点

  • 2023 年，消耗品领域以 68.1% 的份额占据市场主导地位。由于西方印渍术方法的敏感度、效率和特异性不断提高，耗材领域实现了巨大的需求。
  • 疾病诊断领域主导西方印渍术市场，2023年销售份额为60.4%。 V因子、疱疹症状病毒（HSV）、B型肝炎病毒（HBV）、莱姆病、癌症等慢性疾病和自体免疫疾病发生率的增加是推动该细分市场成长的因素。
  • 製药和生物技术公司细分市场占据主导地位，2023 年收益占有率为 32.0%。对标靶治疗、个人化医疗的日益关注以及对药物发现的投资增加正在促进细分市场的成长。
  • 北美西方印渍术市场在全球市场中占据主导地位，2023 年收益占有率为 41.8%。区域製造公司的存在、蛋白质体学研究投资的增加以及个人化医疗意识的增强正在推动成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章西方印渍术市场变数、趋势、范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 西方印渍术市场分析工具
    • 波特的分析
    • PESTEL分析

第四章西方印渍术市场：类型估计和趋势分析

  • 细分仪表板
  • 西方印渍术市场：类型变化分析，百万美元，2023-2030 年
  • 装置
  • 消耗品

第五章西方印渍术市场：应用评估与趋势分析

  • 细分仪表板
  • 西方印渍术市场：应用变化分析，百万美元，2023-2030 年
  • 生物医学/生化研究
  • 疾病诊断
    • HIV
    • 莱姆病
    • 肝炎
    • 其他疾病
  • 农业
  • 其他的

第六章西方印渍术市场：最终用途估计和趋势分析

  • 细分仪表板
  • 西方印渍术市场：最终用途变异分析，百万美元，2023-2030
  • 学术/研究机构
  • 製药和生物技术公司
  • 诊断中心
  • 其他的

第七章西方印渍术市场：区域估计和趋势分析

  • 西方印渍术市场占有率（按地区），2023 年和 2030 年，百万美元
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第八章 竞争格局

  • 最新趋势与影响分析：主要市场参与企业
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • LI-COR Biosciences Inc.
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd
    • Bio-Techne Corporation
    • GE HealthCare
    • PerkinElmer, Inc.
    • Advansta, Inc.
    • Cell Signaling Technology
简介目录
Product Code: GVR-1-68038-709-4

Western Blotting Market Growth & Trends:

The global western blotting market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising number of cases with HIV are increasingly contributing towards the growth of market. This kind of testing is highly effective in detecting HIV among people. According to UNAIDS, nearly 36.7 million people were living with HIV throughout the world in 2015. Such high prevalence of HIV is expected to accelerate the demand for products used in western blotting. Lyme diseases also require western blotting to detect Borrelia burgdorferi (Bb), which causes such diseases. Other diseases which require western blot for detection of specific proteins include mad cow disease, hepatitis, and feline immunodeficiency.

Moreover, significant investments in R&D activities made by pharmaceutical and biotechnology companies are expected to foster growth of western blotting market. According to a news journal, biotech companies spent USD 40.1 billion in 2015 on R&D activities, which was a 16% rise from their 2014 investments. Hence, with rising number of R&D activities, there is an expected rise in the demand for western blotting tests in the near future.

Western Blotting Market Report Highlights:

  • The consumables segment dominated the market with a share of 68.1% in 2023. The consumables segment witnessed a significant demand based on the augmented sensitivity, efficiency, and specificity of the western blotting method.
  • The disease diagnostics segment dominated the western blotting market with a revenue share of 60.4% in 2023. The growing incidences of Factor V, Herplex Symptoms Virus (HSV), Hepatitis B Virus (HBV), and Lyme sickness, incidences of chronic diseases such as cancers, and autoimmune disorders account for segment growth.
  • The pharmaceutical and biotechnology companies segment dominated the market with a revenue share of 32.0% in 2023. The growing focus on targeted treatment, personalized medicine, and increasing investment in drug discovery contribute to the segment growth.
  • North America western blotting market dominated the global market with a revenue share of 41.8% in 2023. The presence of manufacturing companies in the region, growing investment in proteomics studies, and a growing awareness of customized medicine encourage growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Western Blotting Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Western Blotting Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Western Blotting Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Western Blotting Market: Type Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Gel Electrophoresis Instruments
      • 4.3.2.1. Gel Electrophoresis Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Blotting Systems
      • 4.3.3.1. Blotting Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.2. Semi-Dry Blotting Instruments
        • 4.3.3.2.1. Semi-Dry Blotting Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.3.3. Wet Blotting Instruments
        • 4.3.3.3.1. Wet Blotting Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Imagers
      • 4.3.4.1. Imagers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.2. Chemiluminescent Imagers
        • 4.3.4.2.1. Chemiluminescent Imagers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.4.3. Fluorescent Imagers
        • 4.3.4.3.1. Fluorescent Imagers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Reagents and Buffers
      • 4.4.2.1. Reagents and Buffers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Antibodies and Conjugates
      • 4.4.3.1. Antibodies and Conjugates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Primary Antibodies
      • 4.4.4.1. Primary Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2. Secondary Antibodies
        • 4.4.4.2.1. Secondary Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Other Antibodies and Conjugates
      • 4.4.5.1. Other Antibodies and Conjugates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Kits
      • 4.4.6.1. Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Membranes and Filters
      • 4.4.7.1. Membranes and Filters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.8. Other Consumables
      • 4.4.8.1. Other Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Western Blotting Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Western Blotting Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Biomedical & Biochemical Research
    • 5.3.1. Biomedical & Biochemical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Disease Diagnostics
    • 5.4.1. Disease Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. HIV
      • 5.4.2.1. HIV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Lyme Disease
      • 5.4.3.1. Lyme Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Hepatitis
      • 5.4.4.1. Hepatitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Other Diseases
      • 5.4.5.1. Other Diseases Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 5.5. Agriculture
    • 5.5.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Western Blotting Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Western Blotting Market: End Use Movement Analysis, USD Million, 2023 & 2030
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Western Blotting Market: Regional Estimates & Trend Analysis

  • 7.1. Western Blotting Market Share, By Region, 2023 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Western Blotting Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Bio-Rad Laboratories, Inc.
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. LI-COR Biosciences Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. F. Hoffmann-La Roche Ltd
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bio-Techne Corporation
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. GE HealthCare
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. PerkinElmer, Inc.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Advansta, Inc.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Cell Signaling Technology
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives